SCHEMBL25970342

SCHEMBL25970342

CN1C(=O)OC2(CCCC2)[C@@H]2CCC[C@@H]21

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.35
ALDH1A1 P00352 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25985270 0.71 CHRNA7 (0.34) CHRNA7ALDH1A1
SCHEMBL25970518 0.71 CHRNA7 (0.34) CHRNA7ALDH1A1
SCHEMBL25970350 0.64 ALDH1A1 (0.31) ALDH1A1L3MBTL1
SCHEMBL13444673 0.63 LMNA (0.34) ALDH1A1
SCHEMBL10308935 0.62 GRM5 (0.35) ALDH1A1
SCHEMBL23602724 0.60 HSD11B1 (0.33) ALDH1A1L3MBTL1
SCHEMBL22107642 0.59 CHRNA7 (0.39) CHRNA7
SCHEMBL24059773 0.59 ALDH1A1 (0.37) CHRNA7ALDH1A1
SCHEMBL24832939 0.58 KMT2A (0.50) ALDH1A1
SCHEMBL14114609 0.58 GRM5 (0.35) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718638-B2 Compounds, compositions and methods for synthesis ALKBH1, DUT, RNGTT CHRNA7 2395/4885ALDH1A1 2134/4885L3MBTL1 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.